Press release
-
Press Release
National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions
The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2…
Read More » -
Press Release
Leidos completes $2.4 billion acquisition of ENTRUST
RESTON, Va., March 30, 2026 /PRNewswire/ — Leidos (NYSE:LDOS) has completed its previously announced approximately $2.4 billion acquisition of ENTRUST Solutions…
Read More » -
Press Release
National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions
The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2…
Read More » -
Press Release
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG) induced accumulation of TOP1…
Read More » -
Press Release
Leidos completes $2.4 billion acquisition of ENTRUST
RESTON, Va., March 30, 2026 /PRNewswire/ — Leidos (NYSE:LDOS) has completed its previously announced approximately $2.4 billion acquisition of ENTRUST Solutions…
Read More » -
Press Release
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG) induced accumulation of TOP1…
Read More » -
Press Release
Search Homes and See What You Can Afford with the New Realtor.com® App in ChatGPT
The app simplifies critical budget and location decisions for home shoppers, while also safeguarding MLS data AUSTIN, Texas, March 30,…
Read More » -
Press Release
Leidos completes $2.4 billion acquisition of ENTRUST
RESTON, Va., March 30, 2026 /PRNewswire/ — Leidos (NYSE:LDOS) has completed its previously announced approximately $2.4 billion acquisition of ENTRUST Solutions…
Read More » -
Press Release
Search Homes and See What You Can Afford with the New Realtor.com® App in ChatGPT
The app simplifies critical budget and location decisions for home shoppers, while also safeguarding MLS data AUSTIN, Texas, March 30,…
Read More » -
Press Release
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG) induced accumulation of TOP1…
Read More »
